Gilead Sciences

(GILD) - Get Report

announced that it has delivered a notice of termination to F. Hoffman-La Roche claiming breach of their 1996 development and license agreement for Tamiflu, which is an antiviral pill for the treatment and prevention of influenza. Gilead said it is seeking to terminate the agreement and take control of the drug. "Despite our repeated communication of concerns over the last several years, Roche has not adequately demonstrated the requisite commitment to Tamiflu since its launch in the United States nearly six years ago, nor has it allocated the necessary resources to realize the potential of the product as a treatment and preventive for influenza." The stock was up $1.33, or 3.2%, to $42.75 in after-hours trading.

Pactiv

(PTV)

announced that it will sell its North American and European protective and flexible packaging businesses for $530 million and the assumption of certain liabilities, to an affiliate of private equity firm AEA Investors. The specialty packaging company said it will retain its European molded fiber business and Asian operations which had sales last year of $120 million. The sale is expected to close in the third quarter. The stock was unchanged at $21.75.

Medtronic

(MDT) - Get Report

announced that its board has approved a dividend of 9.625 cents a share, which is an increase of 15% over its old payout. The company said the dividend is consistent with its history of paying out about 20% of prior year earnings in the form of cash dividends. The dividend will be payable on July 29 to shareholders of record as of July 1. The stock was unchanged at $51.64.

Tektronix

(TEK)

said it earned $21.2 million, or 24 cents a share, for the fourth quarter ended May 28, compared with $26.1 million, or 30 cents a share, a year ago. Revenue for the quarter was $261 million, an increase of 1% from $257.8 million last year. Excluding certain items, the company the said its profit from continuing operations would have been 31 cents a share. Analysts expected earnings of 30 cents a share on revenue of $255.5 million, according to Thomson First Call. For the first quarter, the company expects earnings from continuing operations, excluding certain items, of 20 cents to 26 cents a share on revenue in the range of $230 million to $240 million. The stock was down $1.13, or 5%, to $22.83 in after-hours trading.

Tibco Software

(TIBX)

said it earned $21.7 million, or 10 cents a share, for the second quarter ended May 29, compared with $9.6 million, or 5 cents a share, a year ago. Revenue for the quarter was $101.4 million, up from $81.2 million last year. Excluding certain items, the company earned $8.6 million, or 4 cents a share. Analysts expected earnings of 4 cents a share on revenue of $101.4 million.

The company said license revenue fell to $41.8 million from $45.3 million a year ago, while maintenance and service revenue rose to $59.6 million from $35.9 million. The stock was down 40 cents, or 5.8%, to $6.51 on Instinet.

Solectron

(SLR)

reported a loss of $67 million, or 7 cents a share, for the third quarter ended May 31, versus a loss of $65 million, or 8 cents a share, a year ago. Revenue for the quarter fell to $2.6 billion from $3.03 billion a year ago. Excluding certain items, the company earned $36 million, or 4 cents a share. Analysts expected a profit of 4 cents a share on revenue of $2.71 billion, according to Thomson First Call. The stock was down 6 cents, or 1.6%, to $3.76.

Finish Line

(FINL)

reported earnings of $12.7 million, or 26 cents a share, for the first quarter ended May 28, up from $10.4 million, or 21 cents a share, a year ago. The athletic retailer said revenue fro the quarter was increased 13% to $291.3 million from $258 million last year. Analysts expected earnings of 26 cents a share on sales of $294.8 million, according to Thomson First Call. The stock was down 36 cents, or 1.8%, or to $19.35 on Instinet.

OmniVision

(OVTI)

said it earned $17.7 million, or 30 cents a share, for the fourth quarter ended April 30, versus $20.8 million, or 34 cents a share, a year ago. Revenue for the quarter was $103 million. Analysts expected earnings of 31 cents a share, according to Thomson First Call. For the first quarter the company expects to earn 22 cents to 27 cents a share on revenue of $90 million to $100 million. Wall Street was expecting profits of 30 cents a share on revue of $98 million.

OmniVision also said it received a letter from the

Securities and Exchange Commission

stating that the SEC has terminated its informal inquiry into certain matters and that no enforcement action will take place. The stock was down 70 cents, or 4.75%, to $14.05 on Instinet.